These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 32109968)

  • 1. Exploration of the Relationship Between Gut Microbiota and Polycystic Ovary Syndrome (PCOS): a Review.
    Zhao X; Jiang Y; Xi H; Chen L; Feng X
    Geburtshilfe Frauenheilkd; 2020 Feb; 80(2):161-171. PubMed ID: 32109968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Balancing Act: Exploring the Gut Microbiota-Brown Adipose Tissue Axis in PCOS Pathogenesis and Therapeutic Frontiers.
    Li Y; Fang Y; Wang H; Zhang H
    Front Biosci (Landmark Ed); 2024 May; 29(6):208. PubMed ID: 38940030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of gut microbiota on omega-3-mediated ovary and metabolic benefits in polycystic ovary syndrome mice.
    Zhang H; Zheng L; Li C; Jing J; Li Z; Sun S; Xue T; Zhang K; Xue M; Cao C; Ouyang L; Qian Z; Xu R; He Z; Ma R; Chen L; Yao B
    J Ovarian Res; 2023 Jul; 16(1):138. PubMed ID: 37443082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut Microbiome and Polycystic Ovary Syndrome: Interplay of Associated Microbial-Metabolite Pathways and Therapeutic Strategies.
    Babu A; Devi Rajeswari V; Ganesh V; Das S; Dhanasekaran S; Usha Rani G; Ramanathan G
    Reprod Sci; 2024 Jun; 31(6):1508-1520. PubMed ID: 38228976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Present and Future: Crosstalks Between Polycystic Ovary Syndrome and Gut Metabolites Relating to Gut Microbiota.
    Zhang M; Hu R; Huang Y; Zhou F; Li F; Liu Z; Geng Y; Dong H; Ma W; Song K; Song Y
    Front Endocrinol (Lausanne); 2022; 13():933110. PubMed ID: 35928893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploration of the pathogenesis of polycystic ovary syndrome based on gut microbiota: A review.
    Guo H; Luo J; Lin H
    Medicine (Baltimore); 2023 Dec; 102(50):e36075. PubMed ID: 38115365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Sleeve Gastrectomy on Fecal Gut Microbiota and Short-Chain Fatty Acid Content in a Rat Model of Polycystic Ovary Syndrome.
    Lin W; Wen L; Wen J; Xiang G
    Front Endocrinol (Lausanne); 2021; 12():747888. PubMed ID: 34858330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating the therapeutic potential of moxibustion on polycystic ovary syndrome: a rat model study on gut microbiota and metabolite interaction.
    Lin Y; Zeng H; Lin J; Peng Y; Que X; Wang L; Chen L; Bai N
    Front Cell Infect Microbiol; 2024; 14():1328741. PubMed ID: 38665877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A New Approach to Polycystic Ovary Syndrome: The Gut Microbiota.
    Yurtdaş G; Akdevelioğlu Y
    J Am Coll Nutr; 2020; 39(4):371-382. PubMed ID: 31513473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polycystic Ovary Syndrome: Etiology, Current Management, and Future Therapeutics.
    Singh S; Pal N; Shubham S; Sarma DK; Verma V; Marotta F; Kumar M
    J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36835989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota as the critical correlation of polycystic ovary syndrome and type 2 diabetes mellitus.
    Duan L; An X; Zhang Y; Jin D; Zhao S; Zhou R; Duan Y; Zhang Y; Liu X; Lian F
    Biomed Pharmacother; 2021 Oct; 142():112094. PubMed ID: 34449321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The latest reports and treatment methods on polycystic ovary syndrome.
    Stańczak NA; Grywalska E; Dudzińska E
    Ann Med; 2024 Dec; 56(1):2357737. PubMed ID: 38965663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the gut microbiota and innate immunity in polycystic ovary syndrome: Current updates and future prospects.
    Zhou M; Yu J; Li X; Ruan Z; Yu S
    J Cell Mol Med; 2024 Apr; 28(8):e18258. PubMed ID: 38546608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Branched-Chain Amino Acids in Metabolic Changes of Polycystic Ovary Syndrome.
    Jia FC; Li XL
    Obstet Gynecol Surv; 2024 Jun; 79(6):343-347. PubMed ID: 38896430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota dysbiosis in polycystic ovary syndrome: Mechanisms of progression and clinical applications.
    Sun Y; Gao S; Ye C; Zhao W
    Front Cell Infect Microbiol; 2023; 13():1142041. PubMed ID: 36909735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probiotic
    Zhang J; Sun Z; Jiang S; Bai X; Ma C; Peng Q; Chen K; Chang H; Fang T; Zhang H
    mSystems; 2019; 4(2):. PubMed ID: 31020040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the role of gut microbiota in obesity and PCOS: Current updates and future prospects.
    Zhang H; Butoyi C; Yuan G; Jia J
    Diabetes Res Clin Pract; 2023 Aug; 202():110781. PubMed ID: 37331521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Yulin Tong Bu formula on modulating gut microbiota and fecal metabolite interactions in mice with polycystic ovary syndrome.
    Su YN; Wang MJ; Yang JP; Wu XL; Xia M; Bao MH; Ding YB; Feng Q; Fu LJ
    Front Endocrinol (Lausanne); 2023; 14():1122709. PubMed ID: 36814581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intersection of Polycystic Ovary Syndrome and the Gut Microbiome.
    Rizk MG; Thackray VG
    J Endocr Soc; 2021 Feb; 5(2):bvaa177. PubMed ID: 33381671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut Microbiota and Polycystic Ovary Syndrome (PCOS): Understanding the Pathogenesis and the Role of Probiotics as a Therapeutic Strategy.
    Salehi S; Allahverdy J; Pourjafar H; Sarabandi K; Jafari SM
    Probiotics Antimicrob Proteins; 2024 Oct; 16(5):1553-1565. PubMed ID: 38421576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.